The9 expects 15%-16% stake in Nanyang Biologics after planned Nasdaq SPAC merger

Reuters2026/08/21 12:32

The9’s investee Nanyang Biologics moved closer to a Nasdaq listing via a planned business combination with RF Acquisition Corp II.
On Aug. 19, 2026, RFAI shareholders backed the deal, clearing a key step toward trading under ticker “NYB.”
The9 expects to own about 15% to 16% of the combined Nasdaq-listed company once the transaction closes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The9 Limited published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A report from Goldman Sachs shows that turbulence in the US stock market in July triggered the largest deleveraging by hedge funds in nearly a decade, with AI-related positions, which previously led gains, experiencing the deepest corrections. However, capital has not withdrawn from the main sectors, as Amazon has remained the top holding for 11 consecutive quarters, and nine of the ten most popular stocks are related to AI. At the same time, funds have reduced crowding risks by increasing allocations to healthcare, financial, and energy sectors, and have also extended their layouts along industry chains such as data centers and AI infrastructure.

华尔街见闻•2026/08/21 13:26

Donegal Mutual Insurance reports $362,931 purchase of Donegal Group Class A shares

Reuters•2026/08/21 13:23

SMT Scharf to publish half-year financial report update

Reuters•2026/08/21 13:22

The9 expects 15%-16% stake in Nanyang Biologics after planned Nasdaq SPAC merger

You may also like

Trending news

Crypto prices